Rank | Gene Set | Z-score |
---|---|---|
1 | cardiac myofibril assembly (GO:0055003) | 7.18835083 |
2 | sarcomere organization (GO:0045214) | 7.08314062 |
3 | tricarboxylic acid cycle (GO:0006099) | 6.37492078 |
4 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.20087264 |
5 | myofibril assembly (GO:0030239) | 6.10553203 |
6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.99040107 |
7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.78943770 |
8 | cardiac muscle contraction (GO:0060048) | 5.68628896 |
9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.63852730 |
10 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.56615909 |
11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.54356916 |
12 | C21-steroid hormone biosynthetic process (GO:0006700) | 5.51569344 |
13 | regulation of actin filament-based movement (GO:1903115) | 5.15252198 |
14 | cardiac muscle cell development (GO:0055013) | 5.14412831 |
15 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.13923587 |
16 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.12681899 |
17 | adult heart development (GO:0007512) | 4.86663668 |
18 | cardiac cell development (GO:0055006) | 4.79577170 |
19 | regulation of relaxation of muscle (GO:1901077) | 4.78045903 |
20 | NADH metabolic process (GO:0006734) | 4.74665926 |
21 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.73004127 |
22 | carnitine shuttle (GO:0006853) | 4.72476843 |
23 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.71998677 |
24 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.69492673 |
25 | cardiac muscle hypertrophy (GO:0003300) | 4.65776081 |
26 | plasma membrane repair (GO:0001778) | 4.64592419 |
27 | actin-myosin filament sliding (GO:0033275) | 4.61802820 |
28 | muscle filament sliding (GO:0030049) | 4.61802820 |
29 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.61083132 |
30 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.53378479 |
31 | actomyosin structure organization (GO:0031032) | 4.47549751 |
32 | cell communication involved in cardiac conduction (GO:0086065) | 4.43952580 |
33 | cell communication by electrical coupling (GO:0010644) | 4.42911516 |
34 | striated muscle hypertrophy (GO:0014897) | 4.39551415 |
35 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.37653606 |
36 | regulation of cofactor metabolic process (GO:0051193) | 4.36385907 |
37 | regulation of coenzyme metabolic process (GO:0051196) | 4.36385907 |
38 | cellular response to epinephrine stimulus (GO:0071872) | 4.35591321 |
39 | glucocorticoid biosynthetic process (GO:0006704) | 4.30864640 |
40 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.30104394 |
41 | regulation of striated muscle contraction (GO:0006942) | 4.29513190 |
42 | regulation of the force of heart contraction (GO:0002026) | 4.25545645 |
43 | regulation of cell communication by electrical coupling (GO:0010649) | 4.25518660 |
44 | regulation of sequestering of triglyceride (GO:0010889) | 4.23081553 |
45 | regulation of membrane repolarization (GO:0060306) | 4.20359776 |
46 | heart trabecula formation (GO:0060347) | 4.16023351 |
47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.14197542 |
48 | regulation of sarcomere organization (GO:0060297) | 4.12340695 |
49 | hormone biosynthetic process (GO:0042446) | 4.10699808 |
50 | striated muscle contraction (GO:0006941) | 4.08145876 |
51 | response to epinephrine (GO:0071871) | 4.07946891 |
52 | fatty acid transmembrane transport (GO:1902001) | 4.06418557 |
53 | muscle tissue morphogenesis (GO:0060415) | 4.02493621 |
54 | toxin metabolic process (GO:0009404) | 4.01863177 |
55 | cellular response to gonadotropin stimulus (GO:0071371) | 4.00948912 |
56 | regulation of skeletal muscle contraction (GO:0014819) | 4.00442094 |
57 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.94663594 |
58 | regulation of cardiac muscle contraction (GO:0055117) | 3.94314595 |
59 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.91467666 |
60 | respiratory electron transport chain (GO:0022904) | 3.88692130 |
61 | muscle hypertrophy (GO:0014896) | 3.84985963 |
62 | actin-mediated cell contraction (GO:0070252) | 3.82771820 |
63 | electron transport chain (GO:0022900) | 3.80324186 |
64 | relaxation of cardiac muscle (GO:0055119) | 3.76641268 |
65 | ketone biosynthetic process (GO:0042181) | 3.76144489 |
66 | estrogen biosynthetic process (GO:0006703) | 3.74148178 |
67 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.71526778 |
68 | heart contraction (GO:0060047) | 3.71464894 |
69 | heart process (GO:0003015) | 3.71464894 |
70 | glucocorticoid metabolic process (GO:0008211) | 3.65980510 |
71 | regulation of heart rate (GO:0002027) | 3.62471457 |
72 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.61086181 |
73 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.60303868 |
74 | ATP synthesis coupled proton transport (GO:0015986) | 3.60303868 |
75 | benzene-containing compound metabolic process (GO:0042537) | 3.59989252 |
76 | response to follicle-stimulating hormone (GO:0032354) | 3.57055227 |
77 | cellular response to antibiotic (GO:0071236) | 3.52708504 |
78 | carnitine transmembrane transport (GO:1902603) | 3.52281622 |
79 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.51363851 |
80 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.49909652 |
81 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.49389460 |
82 | behavioral response to nicotine (GO:0035095) | 3.49384990 |
83 | cardiac muscle cell action potential (GO:0086001) | 3.48673777 |
84 | oxidative phosphorylation (GO:0006119) | 3.45776193 |
85 | 2-oxoglutarate metabolic process (GO:0006103) | 3.45263160 |
86 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.44499343 |
87 | muscle hypertrophy in response to stress (GO:0003299) | 3.44499343 |
88 | cardiac muscle adaptation (GO:0014887) | 3.44499343 |
89 | regulation of heart contraction (GO:0008016) | 3.44126254 |
90 | regulation of sulfur metabolic process (GO:0042762) | 3.43811171 |
91 | C21-steroid hormone metabolic process (GO:0008207) | 3.42838456 |
92 | cellular response to toxic substance (GO:0097237) | 3.40580905 |
93 | regulation of cardioblast differentiation (GO:0051890) | 3.38798168 |
94 | regulation of fatty acid oxidation (GO:0046320) | 3.38671884 |
95 | succinate metabolic process (GO:0006105) | 3.38295448 |
96 | cardiac conduction (GO:0061337) | 3.34719043 |
97 | negative regulation of potassium ion transport (GO:0043267) | 3.34195472 |
98 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.33662409 |
99 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.33258937 |
100 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.30976373 |
101 | oxygen transport (GO:0015671) | 3.30353213 |
102 | dendritic spine morphogenesis (GO:0060997) | 3.29920566 |
103 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.28895975 |
104 | cellular response to cadmium ion (GO:0071276) | 3.28387361 |
105 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.28186259 |
106 | response to insecticide (GO:0017085) | 3.27876675 |
107 | androgen biosynthetic process (GO:0006702) | 3.24799521 |
108 | positive regulation of glycolytic process (GO:0045821) | 3.23049810 |
109 | fatty acid beta-oxidation (GO:0006635) | 3.21984044 |
110 | atrial cardiac muscle cell action potential (GO:0086014) | 3.21093739 |
111 | carnitine transport (GO:0015879) | 3.19076666 |
112 | amino-acid betaine transport (GO:0015838) | 3.19076666 |
113 | response to corticosterone (GO:0051412) | 3.18657540 |
114 | negative regulation of protein localization to cell surface (GO:2000009) | 3.18493353 |
115 | progesterone metabolic process (GO:0042448) | 3.15826202 |
116 | positive regulation of heart contraction (GO:0045823) | 3.14895513 |
117 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.14323262 |
118 | androgen metabolic process (GO:0008209) | 3.11440379 |
119 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.09703829 |
120 | Leydig cell differentiation (GO:0033327) | 3.07400635 |
121 | insulin secretion (GO:0030073) | 3.07347139 |
122 | cellular ketone body metabolic process (GO:0046950) | 3.03570556 |
123 | endocrine pancreas development (GO:0031018) | 2.98517559 |
124 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.95108642 |
125 | nitric oxide mediated signal transduction (GO:0007263) | 2.94807907 |
126 | membrane repolarization during action potential (GO:0086011) | 2.91092922 |
127 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.90799051 |
128 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.84572208 |
129 | regulation of male gonad development (GO:2000018) | 2.82138133 |
130 | proline transport (GO:0015824) | 2.81454326 |
131 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.81440723 |
132 | response to gonadotropin (GO:0034698) | 2.79782768 |
133 | negative regulation of neurological system process (GO:0031645) | 2.79689762 |
134 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.76318158 |
135 | regulation of transmission of nerve impulse (GO:0051969) | 2.75767553 |
136 | positive regulation of amino acid transport (GO:0051957) | 2.73793634 |
137 | platelet dense granule organization (GO:0060155) | 2.71995425 |
138 | ketone body metabolic process (GO:1902224) | 2.67939418 |
139 | gamma-aminobutyric acid transport (GO:0015812) | 2.64616859 |
140 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.63897538 |
141 | parental behavior (GO:0060746) | 2.63801064 |
142 | maternal behavior (GO:0042711) | 2.62044784 |
143 | regulation of female receptivity (GO:0045924) | 2.61796181 |
144 | negative regulation of gluconeogenesis (GO:0045721) | 2.60198453 |
145 | response to mineralocorticoid (GO:0051385) | 2.53974803 |
146 | potassium ion export (GO:0071435) | 2.53766925 |
147 | behavioral response to ethanol (GO:0048149) | 2.53530654 |
148 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.52815182 |
149 | glycerophospholipid catabolic process (GO:0046475) | 2.51729096 |
150 | response to lipoprotein particle (GO:0055094) | 2.51180979 |
151 | aggressive behavior (GO:0002118) | 2.50735699 |
152 | alanine transport (GO:0032328) | 2.50685704 |
153 | response to leptin (GO:0044321) | 2.49147099 |
154 | adrenal gland development (GO:0030325) | 2.47601355 |
155 | cyclic nucleotide catabolic process (GO:0009214) | 2.47075625 |
156 | response to pheromone (GO:0019236) | 2.46719135 |
157 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.46097877 |
158 | detection of calcium ion (GO:0005513) | 2.45410160 |
159 | negative regulation of hormone metabolic process (GO:0032351) | 2.44792384 |
160 | regulation of hexokinase activity (GO:1903299) | 2.44464844 |
161 | regulation of glucokinase activity (GO:0033131) | 2.44464844 |
162 | inositol phosphate catabolic process (GO:0071545) | 2.44233129 |
163 | estrogen metabolic process (GO:0008210) | 2.43178149 |
164 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.43044883 |
165 | positive regulation of insulin secretion (GO:0032024) | 2.40704777 |
166 | positive regulation of meiosis (GO:0045836) | 2.40193637 |
167 | fucose catabolic process (GO:0019317) | 2.39741403 |
168 | L-fucose metabolic process (GO:0042354) | 2.39741403 |
169 | L-fucose catabolic process (GO:0042355) | 2.39741403 |
170 | calcium ion import (GO:0070509) | 2.39385316 |
171 | positive regulation of hormone metabolic process (GO:0032352) | 2.39073272 |
172 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.39029663 |
173 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.39029663 |
174 | * negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.38259868 |
175 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.38146429 |
176 | cAMP catabolic process (GO:0006198) | 2.37583049 |
177 | synaptic vesicle maturation (GO:0016188) | 2.35744738 |
178 | reflex (GO:0060004) | 2.35200315 |
179 | negative regulation of protein oligomerization (GO:0032460) | 2.33735937 |
180 | membrane repolarization (GO:0086009) | 2.31695163 |
181 | cellular response to growth hormone stimulus (GO:0071378) | 2.30158175 |
182 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.29562280 |
183 | positive regulation of peptide hormone secretion (GO:0090277) | 2.28978575 |
184 | macroautophagy (GO:0016236) | 2.27906643 |
185 | serotonin metabolic process (GO:0042428) | 2.26424836 |
186 | positive regulation of peptide secretion (GO:0002793) | 2.25017563 |
187 | membrane depolarization during action potential (GO:0086010) | 2.24713495 |
188 | chemosensory behavior (GO:0007635) | 2.24250692 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.23112951 |
2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.91185131 |
3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.79908667 |
4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.77586824 |
5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.46358740 |
6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.29347251 |
7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.92891136 |
8 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.92891136 |
9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.49739842 |
10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.47731282 |
11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.33271457 |
12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.29870729 |
13 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.13389571 |
14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.11992151 |
15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.03283433 |
16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.03283433 |
17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.00229707 |
18 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.99621183 |
19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.98318942 |
20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95079336 |
21 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.91974946 |
22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.90677014 |
23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.90302758 |
24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85881532 |
25 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.85785430 |
26 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.85533508 |
27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.85392128 |
28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.81184863 |
29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.80358617 |
30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.77718058 |
31 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.77095713 |
32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.76917566 |
33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.76658196 |
34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.75228448 |
35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.74328965 |
36 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.70439073 |
37 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69862735 |
38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.69501055 |
39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.68335281 |
40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.67667142 |
41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.66217934 |
42 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62769387 |
43 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.62343160 |
44 | AR_25329375_ChIP-Seq_VCAP_Human | 1.61382377 |
45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61044090 |
46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.59721009 |
47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59413255 |
48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.59356939 |
49 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.57979361 |
50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.56842872 |
51 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.56641556 |
52 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.52754577 |
53 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.50723732 |
54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47200133 |
55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47016100 |
56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.46368075 |
57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46169945 |
58 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.44600150 |
59 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.44295652 |
60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43065768 |
61 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.42452551 |
62 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.42244745 |
63 | TCF4_23295773_ChIP-Seq_U87_Human | 1.39491125 |
64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.39321353 |
65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39066174 |
66 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37370677 |
67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.36450755 |
68 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36272203 |
69 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.35487640 |
70 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34640671 |
71 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.32923222 |
72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32899816 |
73 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32551756 |
74 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.32196487 |
75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28460711 |
76 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.26647634 |
77 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.25970354 |
78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25510447 |
79 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24203877 |
80 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24203877 |
81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23765051 |
82 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.23396147 |
83 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.22782128 |
84 | EWS_26573619_Chip-Seq_HEK293_Human | 1.21644509 |
85 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20551565 |
86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20445619 |
87 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.20404453 |
88 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.19470092 |
89 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.19470092 |
90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18946999 |
91 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.18681492 |
92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18660274 |
93 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.18236521 |
94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18194997 |
95 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18040035 |
96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17120840 |
97 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16636916 |
98 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13263626 |
99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13226561 |
100 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12594087 |
101 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.12280006 |
102 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.12204088 |
103 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11038673 |
104 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10620007 |
105 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10513754 |
106 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10373856 |
107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10236785 |
108 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09421025 |
109 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09180517 |
110 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08287086 |
111 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.07937381 |
112 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07854920 |
113 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.07683937 |
114 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06610288 |
115 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06143188 |
116 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05657606 |
117 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05657606 |
118 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05646976 |
119 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04931474 |
120 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04746018 |
121 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04394222 |
122 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03445166 |
123 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02997879 |
124 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02939542 |
125 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02744888 |
126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01366172 |
127 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.01250981 |
128 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01170614 |
129 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01026743 |
130 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00568505 |
131 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.00392815 |
132 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.00384576 |
133 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00023100 |
134 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99825263 |
135 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99797507 |
136 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99588101 |
137 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99013576 |
138 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.98868540 |
139 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97835418 |
140 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96827463 |
141 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.96255351 |
142 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.93648282 |
143 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93517689 |
144 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.93304827 |
145 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92819810 |
146 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92613311 |
147 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.90647476 |
148 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.89943507 |
149 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89507807 |
150 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87381863 |
151 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87314563 |
152 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86481513 |
153 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85399755 |
154 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85294736 |
155 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82863389 |
156 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.82551863 |
157 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.81906097 |
158 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80892571 |
159 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80675868 |
160 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80409410 |
161 | AR_19668381_ChIP-Seq_PC3_Human | 0.79508379 |
162 | P68_20966046_ChIP-Seq_HELA_Human | 0.78244047 |
163 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.77822276 |
164 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.77817627 |
165 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.76850679 |
166 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76269936 |
167 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.76031879 |
168 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.74304030 |
169 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.74225791 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 6.75696406 |
2 | MP0004084_abnormal_cardiac_muscle | 5.55972753 |
3 | MP0003646_muscle_fatigue | 5.28395270 |
4 | MP0000751_myopathy | 4.76676431 |
5 | MP0004215_abnormal_myocardial_fiber | 4.56090559 |
6 | MP0004036_abnormal_muscle_relaxation | 4.03162274 |
7 | MP0005330_cardiomyopathy | 3.59078719 |
8 | MP0000749_muscle_degeneration | 3.22048911 |
9 | MP0003283_abnormal_digestive_organ | 3.12556398 |
10 | MP0002972_abnormal_cardiac_muscle | 2.99353648 |
11 | MP0003787_abnormal_imprinting | 2.97934045 |
12 | MP0008775_abnormal_heart_ventricle | 2.94481528 |
13 | MP0003137_abnormal_impulse_conducting | 2.83755613 |
14 | MP0004087_abnormal_muscle_fiber | 2.78544013 |
15 | MP0004130_abnormal_muscle_cell | 2.77640713 |
16 | MP0003195_calcinosis | 2.72974219 |
17 | MP0006138_congestive_heart_failure | 2.69003892 |
18 | MP0001544_abnormal_cardiovascular_syste | 2.58142836 |
19 | MP0005385_cardiovascular_system_phenoty | 2.58142836 |
20 | MP0005379_endocrine/exocrine_gland_phen | 2.47814747 |
21 | MP0005620_abnormal_muscle_contractility | 2.46365495 |
22 | MP0010630_abnormal_cardiac_muscle | 2.43263905 |
23 | MP0004484_altered_response_of | 2.40975189 |
24 | * MP0004085_abnormal_heartbeat | 2.33359901 |
25 | MP0000750_abnormal_muscle_regeneration | 2.19324813 |
26 | MP0008877_abnormal_DNA_methylation | 2.18394149 |
27 | MP0002106_abnormal_muscle_physiology | 2.09025622 |
28 | MP0006276_abnormal_autonomic_nervous | 2.06035161 |
29 | MP0002269_muscular_atrophy | 2.00988400 |
30 | MP0005670_abnormal_white_adipose | 2.00857572 |
31 | MP0005646_abnormal_pituitary_gland | 2.00676803 |
32 | MP0002876_abnormal_thyroid_physiology | 1.99162250 |
33 | MP0001984_abnormal_olfaction | 1.98344803 |
34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.93991462 |
35 | MP0004145_abnormal_muscle_electrophysio | 1.91400835 |
36 | MP0003880_abnormal_central_pattern | 1.90289558 |
37 | MP0003828_pulmonary_edema | 1.90281243 |
38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.86405778 |
39 | MP0002163_abnormal_gland_morphology | 1.80604361 |
40 | MP0008995_early_reproductive_senescence | 1.80247232 |
41 | MP0005551_abnormal_eye_electrophysiolog | 1.79716089 |
42 | MP0005666_abnormal_adipose_tissue | 1.77794015 |
43 | MP0001968_abnormal_touch/_nociception | 1.77305469 |
44 | MP0001501_abnormal_sleep_pattern | 1.75869943 |
45 | MP0000631_abnormal_neuroendocrine_gland | 1.75262159 |
46 | MP0006036_abnormal_mitochondrial_physio | 1.71112758 |
47 | MP0004510_myositis | 1.70907010 |
48 | MP0005369_muscle_phenotype | 1.70851628 |
49 | MP0004233_abnormal_muscle_weight | 1.70550402 |
50 | MP0010386_abnormal_urinary_bladder | 1.70011019 |
51 | MP0005645_abnormal_hypothalamus_physiol | 1.69167201 |
52 | MP0002557_abnormal_social/conspecific_i | 1.63212477 |
53 | MP0000759_abnormal_skeletal_muscle | 1.62642222 |
54 | MP0002127_abnormal_cardiovascular_syste | 1.62074947 |
55 | MP0002693_abnormal_pancreas_physiology | 1.61693893 |
56 | MP0001485_abnormal_pinna_reflex | 1.57384271 |
57 | MP0002572_abnormal_emotion/affect_behav | 1.57218619 |
58 | MP0003011_delayed_dark_adaptation | 1.55224596 |
59 | MP0000747_muscle_weakness | 1.54896759 |
60 | MP0005253_abnormal_eye_physiology | 1.49739570 |
61 | MP0001944_abnormal_pancreas_morphology | 1.48326368 |
62 | MP0001486_abnormal_startle_reflex | 1.48210190 |
63 | MP0002734_abnormal_mechanical_nocicepti | 1.46384814 |
64 | MP0001970_abnormal_pain_threshold | 1.45926720 |
65 | MP0004270_analgesia | 1.42131107 |
66 | MP0002733_abnormal_thermal_nociception | 1.39329522 |
67 | MP0002063_abnormal_learning/memory/cond | 1.38835151 |
68 | * MP0002909_abnormal_adrenal_gland | 1.38600738 |
69 | MP0008004_abnormal_stomach_pH | 1.37515830 |
70 | MP0010329_abnormal_lipoprotein_level | 1.36343043 |
71 | MP0003879_abnormal_hair_cell | 1.35870246 |
72 | MP0005375_adipose_tissue_phenotype | 1.33369441 |
73 | MP0002332_abnormal_exercise_endurance | 1.33163611 |
74 | * MP0000230_abnormal_systemic_arterial | 1.29110894 |
75 | MP0003121_genomic_imprinting | 1.27405029 |
76 | MP0004885_abnormal_endolymph | 1.27355039 |
77 | MP0008872_abnormal_physiological_respon | 1.20731699 |
78 | MP0004185_abnormal_adipocyte_glucose | 1.19687156 |
79 | MP0001986_abnormal_taste_sensitivity | 1.17073831 |
80 | MP0006035_abnormal_mitochondrial_morpho | 1.15909481 |
81 | MP0001905_abnormal_dopamine_level | 1.15116616 |
82 | MP0000343_altered_response_to | 1.12801117 |
83 | MP0002735_abnormal_chemical_nociception | 1.12147204 |
84 | MP0000013_abnormal_adipose_tissue | 1.10691116 |
85 | MP0003950_abnormal_plasma_membrane | 1.10542847 |
86 | MP0002736_abnormal_nociception_after | 1.10523662 |
87 | MP0000266_abnormal_heart_morphology | 1.10522464 |
88 | MP0001502_abnormal_circadian_rhythm | 1.10317432 |
89 | MP0000003_abnormal_adipose_tissue | 1.05153467 |
90 | MP0002234_abnormal_pharynx_morphology | 1.03559361 |
91 | MP0005332_abnormal_amino_acid | 1.03500127 |
92 | MP0005423_abnormal_somatic_nervous | 1.02549900 |
93 | MP0002928_abnormal_bile_duct | 1.02437547 |
94 | MP0003567_abnormal_fetal_cardiomyocyte | 1.01423187 |
95 | MP0004134_abnormal_chest_morphology | 1.00786058 |
96 | MP0002938_white_spotting | 1.00581197 |
97 | MP0005367_renal/urinary_system_phenotyp | 1.00223293 |
98 | MP0000516_abnormal_urinary_system | 1.00223293 |
99 | MP0005220_abnormal_exocrine_pancreas | 1.00094734 |
100 | MP0003633_abnormal_nervous_system | 1.00036422 |
101 | MP0010368_abnormal_lymphatic_system | 0.99609629 |
102 | MP0002184_abnormal_innervation | 0.99433925 |
103 | MP0002822_catalepsy | 0.98827375 |
104 | MP0003279_aneurysm | 0.96793080 |
105 | MP0002229_neurodegeneration | 0.96434694 |
106 | MP0000639_abnormal_adrenal_gland | 0.96028413 |
107 | MP0001756_abnormal_urination | 0.95781562 |
108 | MP0005365_abnormal_bile_salt | 0.94689814 |
109 | MP0002102_abnormal_ear_morphology | 0.92631513 |
110 | MP0004043_abnormal_pH_regulation | 0.91246895 |
111 | MP0004142_abnormal_muscle_tone | 0.90145964 |
112 | MP0005623_abnormal_meninges_morphology | 0.89987630 |
113 | MP0003123_paternal_imprinting | 0.88660708 |
114 | MP0002160_abnormal_reproductive_system | 0.88032108 |
115 | MP0004019_abnormal_vitamin_homeostasis | 0.87608620 |
116 | MP0005165_increased_susceptibility_to | 0.87573787 |
117 | MP0000427_abnormal_hair_cycle | 0.87353457 |
118 | MP0000462_abnormal_digestive_system | 0.85041981 |
119 | MP0002254_reproductive_system_inflammat | 0.82788309 |
120 | MP0005535_abnormal_body_temperature | 0.81422691 |
121 | MP0002971_abnormal_brown_adipose | 0.80495673 |
122 | MP0003045_fibrosis | 0.80261241 |
123 | MP0000538_abnormal_urinary_bladder | 0.78894248 |
124 | MP0002069_abnormal_eating/drinking_beha | 0.77146331 |
125 | MP0002078_abnormal_glucose_homeostasis | 0.76136587 |
126 | MP0004133_heterotaxia | 0.76059547 |
127 | * MP0005636_abnormal_mineral_homeostasis | 0.75852951 |
128 | MP0001879_abnormal_lymphatic_vessel | 0.72440137 |
129 | MP0009780_abnormal_chondrocyte_physiolo | 0.71862540 |
130 | MP0002108_abnormal_muscle_morphology | 0.70323743 |
131 | MP0004924_abnormal_behavior | 0.70308215 |
132 | MP0005386_behavior/neurological_phenoty | 0.70308215 |
133 | MP0008961_abnormal_basal_metabolism | 0.68475406 |
134 | MP0008569_lethality_at_weaning | 0.63936432 |
135 | MP0002128_abnormal_blood_circulation | 0.62246518 |
136 | * MP0001765_abnormal_ion_homeostasis | 0.61642445 |
137 | MP0005266_abnormal_metabolism | 0.61628624 |
138 | MP0004272_abnormal_basement_membrane | 0.55791545 |
139 | MP0005187_abnormal_penis_morphology | 0.55768116 |
140 | * MP0005319_abnormal_enzyme/_coenzyme | 0.55728868 |
141 | MP0003948_abnormal_gas_homeostasis | 0.55284738 |
142 | MP0003122_maternal_imprinting | 0.54675979 |
143 | MP0009046_muscle_twitch | 0.52861065 |
144 | MP0005334_abnormal_fat_pad | 0.49959440 |
145 | * MP0003953_abnormal_hormone_level | 0.49892272 |
146 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48220564 |
147 | MP0003566_abnormal_cell_adhesion | 0.46808238 |
148 | MP0006072_abnormal_retinal_apoptosis | 0.46458170 |
149 | MP0005595_abnormal_vascular_smooth | 0.45838268 |
150 | MP0002118_abnormal_lipid_homeostasis | 0.45251417 |
151 | MP0004147_increased_porphyrin_level | 0.44023550 |
152 | * MP0003635_abnormal_synaptic_transmissio | 0.43498814 |
153 | MP0005452_abnormal_adipose_tissue | 0.41691023 |
154 | MP0005448_abnormal_energy_balance | 0.41345004 |
155 | MP0000767_abnormal_smooth_muscle | 0.41316836 |
156 | MP0002090_abnormal_vision | 0.40587775 |
157 | MP0009115_abnormal_fat_cell | 0.40014626 |
158 | MP0001440_abnormal_grooming_behavior | 0.39501137 |
159 | MP0004859_abnormal_synaptic_plasticity | 0.39047084 |
160 | * MP0002272_abnormal_nervous_system | 0.37267478 |
161 | MP0009745_abnormal_behavioral_response | 0.37096752 |
162 | MP0002970_abnormal_white_adipose | 0.36202189 |
163 | MP0003705_abnormal_hypodermis_morpholog | 0.35986268 |
164 | MP0008438_abnormal_cutaneous_collagen | 0.34903357 |
165 | MP0002638_abnormal_pupillary_reflex | 0.33175292 |
166 | MP0002925_abnormal_cardiovascular_devel | 0.33033567 |
167 | MP0002064_seizures | 0.31883805 |
168 | MP0002067_abnormal_sensory_capabilities | 0.31722443 |
169 | MP0001529_abnormal_vocalization | 0.30834089 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 7.67258056 |
2 | Ventricular tachycardia (HP:0004756) | 6.24736402 |
3 | Atrial fibrillation (HP:0005110) | 6.10010315 |
4 | Primary atrial arrhythmia (HP:0001692) | 5.68711558 |
5 | Calf muscle hypertrophy (HP:0008981) | 5.49455394 |
6 | Supraventricular tachycardia (HP:0004755) | 5.48123279 |
7 | Supraventricular arrhythmia (HP:0005115) | 5.38204325 |
8 | Lipoatrophy (HP:0100578) | 4.96563258 |
9 | Exercise-induced myalgia (HP:0003738) | 4.94802359 |
10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.87519186 |
11 | Syncope (HP:0001279) | 4.82942597 |
12 | Abnormality of the calf musculature (HP:0001430) | 4.65296325 |
13 | Myoglobinuria (HP:0002913) | 4.64946724 |
14 | Prolonged QT interval (HP:0001657) | 4.64570936 |
15 | Muscle fiber splitting (HP:0003555) | 4.59183243 |
16 | Exercise-induced muscle cramps (HP:0003710) | 4.58191486 |
17 | Bundle branch block (HP:0011710) | 4.57087471 |
18 | Palpitations (HP:0001962) | 4.48715474 |
19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.41270338 |
20 | Subaortic stenosis (HP:0001682) | 4.41270338 |
21 | Hypoglycemic seizures (HP:0002173) | 4.40833292 |
22 | Right ventricular cardiomyopathy (HP:0011663) | 4.34974463 |
23 | Dilated cardiomyopathy (HP:0001644) | 4.14649803 |
24 | Hyporeflexia of lower limbs (HP:0002600) | 4.03929829 |
25 | Ventricular fibrillation (HP:0001663) | 3.88251369 |
26 | Heart block (HP:0012722) | 3.85947904 |
27 | Atrioventricular block (HP:0001678) | 3.85509135 |
28 | Ventricular arrhythmia (HP:0004308) | 3.80241323 |
29 | Abnormal atrioventricular conduction (HP:0005150) | 3.61351712 |
30 | Asymmetric septal hypertrophy (HP:0001670) | 3.57018670 |
31 | Hypoplasia of the uterus (HP:0000013) | 3.51441942 |
32 | Hyperglycemia (HP:0003074) | 3.50888619 |
33 | Aplasia/hypoplasia of the uterus (HP:0008684) | 3.47743180 |
34 | Hepatic necrosis (HP:0002605) | 3.45150487 |
35 | EMG: myopathic abnormalities (HP:0003458) | 3.41961709 |
36 | Abnormal EKG (HP:0003115) | 3.38753758 |
37 | Hypothermia (HP:0002045) | 3.36454039 |
38 | Rhabdomyolysis (HP:0003201) | 3.35329642 |
39 | Increased connective tissue (HP:0009025) | 3.26759511 |
40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.22146601 |
41 | Abnormal pancreas size (HP:0012094) | 3.20153496 |
42 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.18744384 |
43 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.18744384 |
44 | Myotonia (HP:0002486) | 3.17645509 |
45 | Ketoacidosis (HP:0001993) | 3.16871260 |
46 | Decreased circulating renin level (HP:0003351) | 3.14887975 |
47 | Acute necrotizing encephalopathy (HP:0006965) | 3.13695233 |
48 | Left ventricular hypertrophy (HP:0001712) | 3.10058761 |
49 | Difficulty running (HP:0009046) | 3.05638368 |
50 | Hepatocellular necrosis (HP:0001404) | 3.02962716 |
51 | Hyperventilation (HP:0002883) | 3.00449310 |
52 | Abnormal drinking behavior (HP:0030082) | 2.99668458 |
53 | Polydipsia (HP:0001959) | 2.99668458 |
54 | Increased muscle lipid content (HP:0009058) | 2.94753699 |
55 | Congenital sensorineural hearing impairment (HP:0008527) | 2.91067154 |
56 | Male pseudohermaphroditism (HP:0000037) | 2.90971973 |
57 | Hypoglycemic coma (HP:0001325) | 2.89350515 |
58 | Enlarged penis (HP:0000040) | 2.86818736 |
59 | Late onset (HP:0003584) | 2.83745558 |
60 | Hemiparesis (HP:0001269) | 2.83579302 |
61 | EEG with generalized epileptiform discharges (HP:0011198) | 2.81238893 |
62 | Epileptiform EEG discharges (HP:0011182) | 2.80456100 |
63 | Pheochromocytoma (HP:0002666) | 2.74119913 |
64 | Abnormal sex determination (HP:0012244) | 2.73813274 |
65 | Sex reversal (HP:0012245) | 2.73813274 |
66 | Acute encephalopathy (HP:0006846) | 2.73562409 |
67 | Congenital stationary night blindness (HP:0007642) | 2.70572659 |
68 | Mitochondrial inheritance (HP:0001427) | 2.68666623 |
69 | Hypsarrhythmia (HP:0002521) | 2.68496871 |
70 | Pancreatic cysts (HP:0001737) | 2.67882095 |
71 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.67392098 |
72 | Symptomatic seizures (HP:0011145) | 2.65378522 |
73 | Abnormality of the renal cortex (HP:0011035) | 2.64551795 |
74 | Hypomagnesemia (HP:0002917) | 2.63685143 |
75 | Hypokalemic alkalosis (HP:0001949) | 2.62847458 |
76 | Progressive macrocephaly (HP:0004481) | 2.62267589 |
77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57623917 |
78 | Dicarboxylic aciduria (HP:0003215) | 2.57623917 |
79 | Type II lissencephaly (HP:0007260) | 2.54575981 |
80 | Nephronophthisis (HP:0000090) | 2.53122165 |
81 | Agitation (HP:0000713) | 2.50800962 |
82 | Molar tooth sign on MRI (HP:0002419) | 2.50480873 |
83 | Abnormality of midbrain morphology (HP:0002418) | 2.50480873 |
84 | Increased CSF lactate (HP:0002490) | 2.50368398 |
85 | Dysmetric saccades (HP:0000641) | 2.49859211 |
86 | Febrile seizures (HP:0002373) | 2.49837806 |
87 | Hypokalemia (HP:0002900) | 2.44715624 |
88 | Gaze-evoked nystagmus (HP:0000640) | 2.41633083 |
89 | Neuroendocrine neoplasm (HP:0100634) | 2.40976835 |
90 | Ragged-red muscle fibers (HP:0003200) | 2.40072272 |
91 | Cerebral edema (HP:0002181) | 2.38842128 |
92 | Focal seizures (HP:0007359) | 2.36770067 |
93 | Increased variability in muscle fiber diameter (HP:0003557) | 2.35784372 |
94 | Conjunctival hamartoma (HP:0100780) | 2.35755579 |
95 | Testicular atrophy (HP:0000029) | 2.35310300 |
96 | Limb dystonia (HP:0002451) | 2.34891296 |
97 | Tubular atrophy (HP:0000092) | 2.33885707 |
98 | Abnormality of the renal medulla (HP:0100957) | 2.33470512 |
99 | Metaphyseal dysplasia (HP:0100255) | 2.30903007 |
100 | Lactic acidosis (HP:0003128) | 2.30784903 |
101 | Pancreatic fibrosis (HP:0100732) | 2.30658073 |
102 | Increased intramyocellular lipid droplets (HP:0012240) | 2.30542490 |
103 | Mesangial abnormality (HP:0001966) | 2.29163923 |
104 | Adrenal overactivity (HP:0002717) | 2.29096362 |
105 | Palmoplantar keratoderma (HP:0000982) | 2.27674222 |
106 | Difficulty climbing stairs (HP:0003551) | 2.23792860 |
107 | Ketosis (HP:0001946) | 2.23754435 |
108 | Respiratory failure (HP:0002878) | 2.20723618 |
109 | Polyuria (HP:0000103) | 2.20323384 |
110 | Abolished electroretinogram (ERG) (HP:0000550) | 2.20136278 |
111 | Neoplasm of the adrenal gland (HP:0100631) | 2.17765073 |
112 | Limb-girdle muscle atrophy (HP:0003797) | 2.17001878 |
113 | Muscle stiffness (HP:0003552) | 2.16253438 |
114 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.15248991 |
115 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.14951290 |
116 | Exercise intolerance (HP:0003546) | 2.13729594 |
117 | Intestinal atresia (HP:0011100) | 2.12848821 |
118 | Hamartoma of the eye (HP:0010568) | 2.12438079 |
119 | Testicular neoplasm (HP:0010788) | 2.12360731 |
120 | True hermaphroditism (HP:0010459) | 2.11099434 |
121 | Central scotoma (HP:0000603) | 2.10582451 |
122 | Abnormality of alanine metabolism (HP:0010916) | 2.10166105 |
123 | Hyperalaninemia (HP:0003348) | 2.10166105 |
124 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.10166105 |
125 | Chronic hepatic failure (HP:0100626) | 2.09500723 |
126 | Large for gestational age (HP:0001520) | 2.09416228 |
127 | Attenuation of retinal blood vessels (HP:0007843) | 2.04888345 |
128 | Esophageal neoplasm (HP:0100751) | 2.01505890 |
129 | Neoplasm of head and neck (HP:0012288) | 2.01505890 |
130 | Absent speech (HP:0001344) | 2.00784443 |
131 | Hyperglycinuria (HP:0003108) | 1.99337816 |
132 | Medial flaring of the eyebrow (HP:0010747) | 1.99321074 |
133 | Progressive cerebellar ataxia (HP:0002073) | 1.98599550 |
134 | Renal salt wasting (HP:0000127) | 1.98165928 |
135 | Abnormality of renin-angiotensin system (HP:0000847) | 1.97610211 |
136 | Prominent metopic ridge (HP:0005487) | 1.97432710 |
137 | Hyperaldosteronism (HP:0000859) | 1.96595334 |
138 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.94305196 |
139 | Broad-based gait (HP:0002136) | 1.93786936 |
140 | Sudden cardiac death (HP:0001645) | 1.93390756 |
141 | Abnormality of the metopic suture (HP:0005556) | 1.92382763 |
142 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92300417 |
143 | Dialeptic seizures (HP:0011146) | 1.90357118 |
144 | Abnormality of magnesium homeostasis (HP:0004921) | 1.90189065 |
145 | Lymphangioma (HP:0100764) | 1.90091338 |
146 | Abnormality of potassium homeostasis (HP:0011042) | 1.90046362 |
147 | Athetosis (HP:0002305) | 1.88284756 |
148 | Distal lower limb muscle weakness (HP:0009053) | 1.87961939 |
149 | Congestive heart failure (HP:0001635) | 1.87883199 |
150 | Focal motor seizures (HP:0011153) | 1.87795399 |
151 | Neck muscle weakness (HP:0000467) | 1.87448478 |
152 | Generalized aminoaciduria (HP:0002909) | 1.86828470 |
153 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.86620637 |
154 | Inability to walk (HP:0002540) | 1.86228137 |
155 | Neoplasm of the adrenal cortex (HP:0100641) | 1.85612647 |
156 | Abnormal urine output (HP:0012590) | 1.85153776 |
157 | Tinnitus (HP:0000360) | 1.83072160 |
158 | Tachypnea (HP:0002789) | 1.82409970 |
159 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82001077 |
160 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.81777558 |
161 | Generalized tonic-clonic seizures (HP:0002069) | 1.81346594 |
162 | Progressive inability to walk (HP:0002505) | 1.80194023 |
163 | Widely spaced teeth (HP:0000687) | 1.80148715 |
164 | Muscular hypotonia of the trunk (HP:0008936) | 1.80115997 |
165 | Broad metatarsal (HP:0001783) | 1.79523288 |
166 | Bradycardia (HP:0001662) | 1.78448040 |
167 | Cystic liver disease (HP:0006706) | 1.76563628 |
168 | Abnormality of the foot musculature (HP:0001436) | 1.76523755 |
169 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.75528263 |
170 | Polyphagia (HP:0002591) | 1.75219735 |
171 | Congenital malformation of the right heart (HP:0011723) | 1.74781200 |
172 | Double outlet right ventricle (HP:0001719) | 1.74781200 |
173 | Anxiety (HP:0000739) | 1.74757446 |
174 | Disproportionate short-trunk short stature (HP:0003521) | 1.74704304 |
175 | Epileptic encephalopathy (HP:0200134) | 1.73506507 |
176 | Gowers sign (HP:0003391) | 1.73051319 |
177 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.71074231 |
178 | Abnormality of renal excretion (HP:0011036) | 1.71028990 |
179 | Increased circulating renin level (HP:0000848) | 1.69275967 |
180 | Hypoproteinemia (HP:0003075) | 1.68168237 |
181 | Abnormal albumin level (HP:0012116) | 1.64751005 |
182 | Hypoalbuminemia (HP:0003073) | 1.64751005 |
183 | Gait imbalance (HP:0002141) | 1.63210156 |
184 | Renal cortical cysts (HP:0000803) | 1.62312817 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 6.69134128 |
2 | TTN | 4.60191694 |
3 | MYLK | 4.05429017 |
4 | LMTK2 | 4.04221911 |
5 | PHKG2 | 3.77970609 |
6 | PHKG1 | 3.77970609 |
7 | PDK4 | 3.41328711 |
8 | PDK3 | 3.41328711 |
9 | TRIB3 | 3.37224309 |
10 | BCKDK | 2.91638773 |
11 | OBSCN | 2.78632099 |
12 | PKN2 | 2.73022354 |
13 | DMPK | 2.65403386 |
14 | ADRBK2 | 2.46669386 |
15 | MAP4K2 | 2.46040250 |
16 | CASK | 2.46023400 |
17 | DAPK2 | 2.40405557 |
18 | PINK1 | 2.19617610 |
19 | MUSK | 2.18829836 |
20 | FGFR2 | 2.15787381 |
21 | PIK3CA | 2.11114209 |
22 | TIE1 | 2.10744879 |
23 | WNK3 | 2.08996886 |
24 | PDK2 | 2.07218861 |
25 | GRK1 | 1.90380133 |
26 | EPHA4 | 1.88143792 |
27 | MARK1 | 1.80312691 |
28 | NEK1 | 1.70535778 |
29 | AKT3 | 1.69005556 |
30 | BMPR1B | 1.68291162 |
31 | STK24 | 1.64316116 |
32 | PAK3 | 1.62225619 |
33 | NLK | 1.61655413 |
34 | TNIK | 1.56099007 |
35 | MAPK13 | 1.43481878 |
36 | RIPK1 | 1.42619854 |
37 | GRK7 | 1.41868012 |
38 | CAMK2D | 1.40727460 |
39 | INSRR | 1.35812297 |
40 | PRKD1 | 1.34704958 |
41 | OXSR1 | 1.33815523 |
42 | WNK4 | 1.29988458 |
43 | MAP2K6 | 1.23906743 |
44 | CDC42BPA | 1.23305638 |
45 | EPHA3 | 1.21769204 |
46 | PRKCG | 1.19412524 |
47 | ILK | 1.14360184 |
48 | TAOK3 | 1.11950986 |
49 | ACVR1B | 1.11652103 |
50 | PLK2 | 1.04520221 |
51 | TLK1 | 1.02958596 |
52 | STK38 | 1.01379978 |
53 | PDGFRA | 1.00981760 |
54 | ROCK1 | 0.97217214 |
55 | ADRBK1 | 0.97091566 |
56 | MAPK12 | 0.96666891 |
57 | WNK1 | 0.95598582 |
58 | MAP3K2 | 0.95561136 |
59 | MST4 | 0.94386441 |
60 | NTRK2 | 0.94271142 |
61 | CSNK1G1 | 0.93725156 |
62 | MAP2K7 | 0.92748811 |
63 | PRKAA1 | 0.91492786 |
64 | CSNK1G2 | 0.85093107 |
65 | STK38L | 0.83352265 |
66 | CAMK1 | 0.83304272 |
67 | CAMK4 | 0.83131746 |
68 | MAP3K7 | 0.83009169 |
69 | CSNK1G3 | 0.81812106 |
70 | PRKAA2 | 0.81363824 |
71 | PKN1 | 0.81199770 |
72 | DYRK2 | 0.80550644 |
73 | SIK1 | 0.80394332 |
74 | DAPK3 | 0.78433614 |
75 | MAP3K4 | 0.76260741 |
76 | CAMK2A | 0.75600146 |
77 | STK39 | 0.73309395 |
78 | FGFR3 | 0.72757862 |
79 | PRKD3 | 0.72150599 |
80 | IRAK1 | 0.71317768 |
81 | PRKCE | 0.70018771 |
82 | PASK | 0.68664020 |
83 | NUAK1 | 0.67392052 |
84 | PRKCH | 0.67242186 |
85 | STK3 | 0.67081606 |
86 | CAMK1G | 0.66305229 |
87 | PAK6 | 0.66167588 |
88 | PRKCZ | 0.65718344 |
89 | PDPK1 | 0.64853066 |
90 | ROCK2 | 0.64586338 |
91 | EIF2AK3 | 0.64201088 |
92 | HIPK2 | 0.63428027 |
93 | PNCK | 0.61910491 |
94 | RPS6KC1 | 0.61505673 |
95 | RPS6KL1 | 0.61505673 |
96 | ICK | 0.60786588 |
97 | CAMK1D | 0.60592920 |
98 | DDR2 | 0.59854025 |
99 | EPHB2 | 0.58617600 |
100 | MAPKAPK3 | 0.57033371 |
101 | CDK5 | 0.56404767 |
102 | CSNK1A1L | 0.55930143 |
103 | PRKACB | 0.55496239 |
104 | PRKCI | 0.55445636 |
105 | PTK2B | 0.55340854 |
106 | MAP3K5 | 0.54071234 |
107 | FER | 0.54007923 |
108 | PRKACG | 0.53747097 |
109 | ZAK | 0.52681916 |
110 | ERBB3 | 0.51972062 |
111 | FLT3 | 0.51721153 |
112 | RPS6KA6 | 0.51270615 |
113 | * PRKACA | 0.50579919 |
114 | TGFBR2 | 0.50307097 |
115 | CSNK1A1 | 0.49862420 |
116 | ERN1 | 0.49839290 |
117 | MAPK15 | 0.49670522 |
118 | SGK3 | 0.49147056 |
119 | PDK1 | 0.47802098 |
120 | TRIM28 | 0.47705165 |
121 | STK4 | 0.47415603 |
122 | MAP2K4 | 0.45363878 |
123 | CAMK2G | 0.44600643 |
124 | MAP3K9 | 0.43044725 |
125 | PRKCA | 0.41300462 |
126 | TRPM7 | 0.40461981 |
127 | PTK6 | 0.40268209 |
128 | RET | 0.38514887 |
129 | KDR | 0.37966289 |
130 | MAPKAPK5 | 0.37687686 |
131 | TNK2 | 0.37053352 |
132 | NTRK3 | 0.36407752 |
133 | CAMKK1 | 0.36056274 |
134 | PRKG2 | 0.34006769 |
135 | CAMKK2 | 0.33959692 |
136 | UHMK1 | 0.31803145 |
137 | LATS2 | 0.31283979 |
138 | RPS6KA2 | 0.30280874 |
139 | MAP2K1 | 0.30174274 |
140 | MAP2K2 | 0.29734498 |
141 | SGK2 | 0.29237918 |
142 | CSNK1D | 0.29009627 |
143 | SGK223 | 0.27635476 |
144 | SGK494 | 0.27635476 |
145 | CAMK2B | 0.26654582 |
146 | SGK1 | 0.26147268 |
147 | EPHB1 | 0.24097145 |
148 | MARK2 | 0.23184230 |
149 | MAP3K3 | 0.22792121 |
150 | PRKG1 | 0.22656467 |
151 | * RPS6KA3 | 0.22610778 |
152 | GRK5 | 0.21702864 |
153 | MAP3K1 | 0.20237121 |
154 | JAK1 | 0.19664007 |
155 | STK11 | 0.19100577 |
156 | RPS6KA1 | 0.19039602 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.71796984 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.46716300 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.87628582 |
4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.73613280 |
5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.29297285 |
6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.06269805 |
7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.95143493 |
8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.87915547 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.80473814 |
10 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.77373541 |
11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.54820622 |
12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.48338814 |
13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.42990464 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31630429 |
15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.23104023 |
16 | Alzheimers disease_Homo sapiens_hsa05010 | 2.21668838 |
17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.10677957 |
18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.94892401 |
19 | Phototransduction_Homo sapiens_hsa04744 | 1.86006709 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.85495371 |
21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82644726 |
22 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.81920334 |
23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.78609374 |
24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.74173690 |
25 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.62231684 |
26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.55886838 |
27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.49191778 |
28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.46294519 |
29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.44186091 |
30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.43973744 |
31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39556855 |
32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39182868 |
33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38321494 |
34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.38194257 |
35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37575183 |
36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36956142 |
37 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.36014135 |
38 | ABC transporters_Homo sapiens_hsa02010 | 1.34097966 |
39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27326591 |
40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22616644 |
41 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.21180336 |
42 | Protein export_Homo sapiens_hsa03060 | 1.20641791 |
43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19150990 |
44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.18477041 |
45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14823210 |
46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.11095722 |
47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10088163 |
48 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.05675339 |
49 | Renin secretion_Homo sapiens_hsa04924 | 1.03754636 |
50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00082753 |
51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.97190868 |
52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94734245 |
53 | Circadian entrainment_Homo sapiens_hsa04713 | 0.94655809 |
54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94634008 |
55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94432011 |
56 | Insulin secretion_Homo sapiens_hsa04911 | 0.91442346 |
57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90813729 |
58 | Mineral absorption_Homo sapiens_hsa04978 | 0.90250391 |
59 | Insulin resistance_Homo sapiens_hsa04931 | 0.89782239 |
60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89426481 |
61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87940978 |
62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87606210 |
63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.86593620 |
64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84639319 |
65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.81780210 |
66 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81272248 |
67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80259986 |
68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80153166 |
69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78727372 |
70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77760736 |
71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77524686 |
72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76499668 |
73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75929189 |
74 | Long-term depression_Homo sapiens_hsa04730 | 0.75921382 |
75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75751696 |
76 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75470938 |
77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72574633 |
78 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.71585444 |
79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69887494 |
80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69542902 |
81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.69221738 |
82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67833486 |
83 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66864732 |
84 | Morphine addiction_Homo sapiens_hsa05032 | 0.66780173 |
85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65467982 |
86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65307931 |
87 | Lysine degradation_Homo sapiens_hsa00310 | 0.64296278 |
88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.64208396 |
89 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.63902221 |
90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63733180 |
91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62548910 |
92 | Salivary secretion_Homo sapiens_hsa04970 | 0.61102028 |
93 | Taste transduction_Homo sapiens_hsa04742 | 0.61019242 |
94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60107112 |
95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59931968 |
96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59128809 |
97 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58980284 |
98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58802326 |
99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57932883 |
100 | GABAergic synapse_Homo sapiens_hsa04727 | 0.57740947 |
101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55819339 |
102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50660753 |
103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50189186 |
104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48571373 |
105 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48443346 |
106 | Focal adhesion_Homo sapiens_hsa04510 | 0.48101204 |
107 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47330913 |
108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46477935 |
109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46225305 |
110 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45446632 |
111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45283075 |
112 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45031890 |
113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41900879 |
114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41560972 |
115 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.40604358 |
116 | Gap junction_Homo sapiens_hsa04540 | 0.39613682 |
117 | Peroxisome_Homo sapiens_hsa04146 | 0.38749026 |
118 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38578523 |
119 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38545004 |
120 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38514059 |
121 | Long-term potentiation_Homo sapiens_hsa04720 | 0.38065030 |
122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37642983 |
123 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.37333471 |
124 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35904927 |
125 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.35514465 |
126 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35307980 |
127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34966877 |
128 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34628451 |
129 | Bile secretion_Homo sapiens_hsa04976 | 0.33812319 |
130 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32711477 |
131 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.32604259 |
132 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32389179 |
133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31622207 |
134 | Nicotine addiction_Homo sapiens_hsa05033 | 0.31160287 |
135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30000407 |
136 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29851942 |
137 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27176828 |
138 | Tight junction_Homo sapiens_hsa04530 | 0.23893787 |
139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23361198 |
140 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.21017168 |
141 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20396531 |
142 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.19011218 |
143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18625699 |
144 | Cocaine addiction_Homo sapiens_hsa05030 | 0.17559899 |
145 | Amoebiasis_Homo sapiens_hsa05146 | 0.16579876 |
146 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.14598942 |